Achieve Life Sciences, Inc. Stock 12‑Month Price Target Cut to $13.83, Implies 107% Upside
Achieve Life Sciences, Inc.'s average 12-month price target has been lowered slightly from $13.91 to $13.83 by 12 analysts, with predictions ranging from $9 to $21 per share. This new target suggests a potential upside of approximately 107% from its closing price on August …